stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Price to free cash flow
As of 6 November 2026, Clover Health Investments, Corp. (CLOV) trades at a price to free cash flow of 19.2×. Over the past ten years it has ranged from 0.0× (March 2026) to 71.0× (January 2025); the current reading is higher than 85% of that period. That is above the Healthcare Plans industry median of 14.8× and below the Healthcare sector median of 20.5×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 46.4× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 17.3× | (53.20%) |
| Jun 2026 | 37.0× | 119.66% |
| Mar 2026 | 16.9× | — |
| Dec 2025 | 0.0× | — |
| 23 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.3× |
| CNC Centene Corporation compare | 8.7× |
| CI Cigna Group compare | 9.3× |
| ELV Elevance Health, Inc. compare | 14.2× |
| PGNY Progyny, Inc. compare | 14.8× |
| HUM Humana Inc. compare | 16.5× |
| CLOV Clover Health Investments, Corp. | 19.2× |
| ALHC Alignment Healthcare, Inc. compare | 19.8× |
| MOH Molina Healthcare, Inc compare | 44.8× |
| Healthcare Plans industry median | 14.8× |
| Healthcare sector median | 20.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement